We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Accurate Diagnosis of Influenza Critical for Better Treatment/Control

By LabMedica International staff writers
Posted on 07 Mar 2012
Patients who present with flu-like symptoms require a rapid, accurate diagnosis before they can be treated. More...


Two new metaanalyses published online in the Annals of Internal Medicine on February 21, 2012, and February 27, 2012, highlight the importance of rapid diagnosis and treatment of flu.

In the first Annals article Mudhukar Pai, MD, PhD, from the University of Alberta (Edmonton, Canada) and colleagues reviewed 159 published studies to determine the accuracy of rapid influenza diagnostic tests (RIDTs) in diagnosing flu in adults and children presenting with flu-like symptoms. In all studies, RIDTs were tested against one of two accepted reference standards.

The scientists found that RIDTs were accurate at diagnosing the flu, but not as accurate at ruling it out, meaning that patients with a negative result would need to follow up with a culture or RT-PCR. RIDTs had an approximately 13 % higher sensitivity in children compared to adults, and were more accurate at detecting the more common influenza virus A compared to influenza virus B. According to the authors, the study results support implementing RIDTs in clinical practice, especially when treating children and other patients at risk for flu-related complications.

In the second Annals study Holger Ishüneman from the Iberamerican Cochrane Center (Barcelona, Spain) and colleagues cited evidence that early treatment with antivirals (within 48 hours) may be of greater benefit than later treatment. The scientists reviewed 74 published observational studies to determine the benefits and harms of four commonly prescribed antivirals: oseltamivir, zanamivir, amantadine, and rimantadine. The investigators found that oral oseltamivir and inhaled zanamivir might provide a net benefit over no treatment for patients with known flu.

Currently used viral cultures are accurate, but turnaround from culture to lab result can take up to 10 days. Newer reverse transcriptase-polymerase chain reaction (RT-PCR) tests are much quicker than viral cultures, but are very expensive and require specialized equipment. RIDTs are inexpensive and simple to use in the physician's office. The two studies described in the Annals of Internal Medicine give more information about their advantages for diagnosing flu, and the antivirals that are most effective.

Related Links:

University of Alberta
Iberamerican Cochrane Center



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.